Literature DB >> 5215559

Combination cytotoxic chemotherapy in advanced disseminated breast carcinoma.

E M Greenspan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5215559

Source DB:  PubMed          Journal:  J Mt Sinai Hosp N Y        ISSN： 0099-9695


× No keyword cloud information.
  16 in total

1.  Systemic chemotherapy of mammary carcinoma.

Authors:  W W Shingleton; N Sedransk; R O Johnson
Journal:  Ann Surg       Date:  1971-06       Impact factor: 12.969

2.  [Cytostatic therapy in breast carcinoma].

Authors:  K Karrer
Journal:  Langenbecks Arch Chir       Date:  1970-12

3.  Adjuvant chemotherapy in stage II breast cancer: a brief overview of the NSABP clinical trials.

Authors:  N Wolmark; B Fisher
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

Review 4.  Current status of chemotherapy of breast cancer.

Authors:  A Coates
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

5.  Mitomycin-C, VP16-213 combination as third line chemotherapy in advanced breast cancer.

Authors:  G Perez Manga; P L Madrigal Alonso; H Alburquerque Carbuccia
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

6.  An evaluation of the effect of vincristine added to cyclophosphamide, 5-fluorouracil, methotrexate, and prednisone in advanced breast cancer.

Authors:  A Segaloff; B F Hankey; A C Carter; G C Escher; F J Ansfield; R W Talley
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 7.  Update on cancer chemotherapy: general considerations and breast cancer. Part II.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-09       Impact factor: 1.798

8.  The effects of multiple combination chemotherapy with vincristine, cyclophosphamide (Endoxan), methotrexate, 5-fluorouracil, adriamycin and prednisolone (VEMFAH) for advanced breast cancer.

Authors:  T Kojima; A Hoshino; K Ohara; O Kamiya; K Nagata; Y Ito; T Kinoshita; I Sugiura; M Yamada; H Sato
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 9.  Drug treatment of breast cancer.

Authors:  T E Davis; P P Carbone
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

10.  Adjuvant chemotherapy in stage-II breast cancer: an overview of the NSABP clinical trials.

Authors:  N Wolmark; B Fisher
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.